Competition among GLP-1 drugs could have a moderating effect on launch prices and lead to higher rebates negotiated between manufacturers and pharmacy benefit managers
May Contain (+/-): Titanium Dioxide (CI 77891), Iron Oxides (CI 77491, CI 77492, CI 77499), Bismuth Oxychloride (CI 77163), Manganese Violet (CI 77742), Red 6 (CI 15850), Red 7 Lake (CI 15850), Red 21(CI 45380), Red 27 (CI 45410), Red 28 Lake (CI 45410), Red 30 Lake (CI 73360), Red 33 Lake (CI 17200), Orange 5 (CI 45370), Yellow 5 Lake (CI 19140), Yellow 6 Lake (CI 15985), Blue 1 Lake (CI 42090)
Weisel RD
This action is presumed to subsequently elevate levels of insulin-like growth factor-1 (IGF-1), recognized as the primary mediator of the anabolic properties of growth hormone
This timing correlates with maximum medication concentration in your bloodstream